Variant report
Variant | esv3331702 |
---|---|
Chromosome Location | chr5:117230102-117259590 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:28)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:28 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:117238164-117238250 | A549 | lung: | n/a | n/a |
2 | CTCF | chr5:117242230-117242302 | GM10248 | blood: | n/a | n/a |
3 | CUX1 | chr5:117251573-117251663 | GM12878 | blood: | n/a | n/a |
4 | E2F4 | chr5:117255351-117255488 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | E2F4 | chr5:117238676-117238808 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | E2F4 | chr5:117241110-117241297 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | GATA3 | chr5:117239495-117239650 | SH-SY5Y | brain: | n/a | n/a |
8 | MAZ | chr5:117236252-117236380 | HepG2 | liver: | n/a | n/a |
9 | MXI1 | chr5:117246961-117247037 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | POLR2A | chr5:117233771-117233971 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | POLR2A | chr5:117259311-117259443 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | POLR2A | chr5:117241193-117241393 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | POLR2A | chr5:117259256-117259380 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr5:117240084-117240213 | MCF-7 | breast: | n/a | n/a |
15 | POLR2A | chr5:117258695-117258852 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr5:117238372-117238899 | H1-neurons | neurons: | n/a | n/a |
17 | POLR2A | chr5:117237974-117237983 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | SPI1 | chr5:117252124-117252307 | GM12878 | blood: | n/a | n/a |
19 | SPI1 | chr5:117252129-117252246 | K562 | blood: | n/a | n/a |
20 | SPI1 | chr5:117252127-117252236 | GM12878 | blood: | n/a | n/a |
21 | SPI1 | chr5:117242466-117242636 | GM12878 | blood: | n/a | n/a |
22 | SPI1 | chr5:117242471-117242639 | K562 | blood: | n/a | n/a |
23 | SPI1 | chr5:117242485-117242630 | K562 | blood: | n/a | n/a |
24 | SPI1 | chr5:117242446-117242635 | GM12891 | blood: | n/a | n/a |
25 | SPI1 | chr5:117252131-117252236 | K562 | blood: | n/a | n/a |
26 | STAT3 | chr5:117239470-117239655 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | STAT3 | chr5:117232449-117232585 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | STAT3 | chr5:117258854-117259054 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249797 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181156605 | chr5:117246255-117246256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569599684 | chr5:117246287-117246288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537831223 | chr5:117246341-117246342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557478460 | chr5:117246350-117246351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs571275141 | chr5:117246361-117246362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533673448 | chr5:117246383-117246384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553900317 | chr5:117246405-117246406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77671404 | chr5:117246433-117246434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542444832 | chr5:117246456-117246457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545872654 | chr5:117246472-117246473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556038676 | chr5:117246478-117246479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs145444389 | chr5:117246503-117246504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547341369 | chr5:117246524-117246525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs56287832 | chr5:117246535-117246536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189555315 | chr5:117246545-117246546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564324862 | chr5:117246560-117246561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76650383 | chr5:117246600-117246601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113373332 | chr5:117246617-117246618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115973287 | chr5:117246678-117246679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143580661 | chr5:117246681-117246682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs76013154 | chr5:117246693-117246694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148044399 | chr5:117246703-117246704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79219061 | chr5:117246742-117246743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs4472293 | chr5:117246760-117246761 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs571172787 | chr5:117246789-117246790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs79662810 | chr5:117246804-117246805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547157714 | chr5:117246807-117246808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140828144 | chr5:117246817-117246818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536026706 | chr5:117246914-117246915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555946550 | chr5:117246917-117246918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6595069 | chr5:117246999-117247000 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs538577087 | chr5:117247020-117247021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570127963 | chr5:117247025-117247026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530807255 | chr5:117247052-117247053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539329940 | chr5:117247094-117247095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182171755 | chr5:117247115-117247116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs79152579 | chr5:117247120-117247121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570590841 | chr5:117247126-117247127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73786754 | chr5:117247128-117247129 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs560379151 | chr5:117247215-117247216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574191193 | chr5:117247237-117247238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114168429 | chr5:117247267-117247268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563098809 | chr5:117247295-117247296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532011030 | chr5:117247309-117247310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551773171 | chr5:117247320-117247321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565602314 | chr5:117247323-117247324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527288866 | chr5:117247343-117247344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs6884578 | chr5:117247348-117247349 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs566979759 | chr5:117247387-117247388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186815205 | chr5:117247395-117247396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22543975 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:117246200-117247000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
2 | chr5:117246200-117247200 | Enhancers | H9 Cell Line | embryonic stem cell |
3 | chr5:117246400-117247400 | Enhancers | H1 Cell Line | embryonic stem cell |
4 | chr5:117246400-117247400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr5:117246600-117247200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr5:117250000-117250200 | Enhancers | Gastric | stomach |